Amedisys Inc. (AMED) Financials Nov 20, 2014, 5:36
Post# of 250666
Posted On: 11/20/2014 7:43:36 PM
Amedisys Inc. (AMED) Financials Nov 20, 2014, 5:36 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Amedisys Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.51B 1.63B 1.47B 1.49B 1.25B
Cost of Goods Sold (COGS) incl. D&A 752.78M 855.05M 820.96M 881.07M 754.87M
COGS excluding D&A 724.47M 820.46M 782.35M 841.01M 717.48M
Depreciation & Amortization Expense 28.31M 34.59M 38.61M 40.06M 37.38M
Depreciation - - 34.4M 37M 35.2M
Amortization of Intangibles - - 4.21M 3.06M 2.18M
Gross Income 760.68M 779.27M 649.4M 606.83M 494.48M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 529.53M 584.56M 536.61M 556.94M 486.66M
Research & Development - - - 0 0
Other SG&A 529.53M 584.56M 536.61M 556.94M 486.66M
Other Operating Expense 0 0 0 0 0
Unusual Expense 400,000 3.4M 583.66M 163.2M 162.79M
EBIT after Unusual Expense (400,000) (3.4M) (583.66M) (163.2M) (162.79M)
Non Operating Income/Expense 760,000 22,000 (840,000) 5.02M 4.33M
Non-Operating Interest Income 213,000 435,000 231,000 65,000 54,000
Equity in Affiliates (Pretax) 2.34M 3.02M 1.49M 1.7M 1.52M
Interest Expense 11.67M 9.2M 8.82M 12.17M 4.41M
Gross Interest Expense 11.67M 9.2M 8.82M 12.17M 4.41M
Interest Capitalized 0 0 0 0 0
Pretax Income 222.39M 185.58M (478.8M) (118.7M) (153.48M)
Income Tax 86.17M 72.31M (103.43M) (21.4M) (58.77M)
Income Tax - Current Domestic 64.57M 46.41M 18.57M 9.8M (1.7M)
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic 21.6M 25.9M (122M) (31.2M) (57.07M)
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 - 0
Equity in Affiliates 0 0 0 - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 136.22M 113.27M (375.38M) (97.3M) (94.7M)
Minority Interest Expense 386,000 693,000 122,000 (15M) (1.6M)
Net Income 135.84M 112.58M (375.5M) (82.31M) (93.11M)
Extraordinaries & Discontinued Operations 0 0 (6.97M) (1.28M) (3.07M)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 (6.97M) (1.28M) (3.07M)
Net Income After Extraordinaries 135.84M 112.58M (382.46M) (83.59M) (96.18M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 135.84M 112.58M (375.5M) (82.31M) (93.11M)
EPS (Basic) 4.99 4.02 (13.33) (2.79) (3.08)
Basic Shares Outstanding 27.23M 28.03M 28.69M 29.9M 31.25M
EPS (Diluted) 4.89 3.95 (13.33) (2.79) (3.08)
Diluted Shares Outstanding 27.76M 28.48M 28.69M 29.9M 31.25M
EBITDA 259.46M 229.3M 151.4M 89.96M 45.2M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Amedisys Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.51B 1.63B 1.47B 1.49B 1.25B
Cost of Goods Sold (COGS) incl. D&A 752.78M 855.05M 820.96M 881.07M 754.87M
COGS excluding D&A 724.47M 820.46M 782.35M 841.01M 717.48M
Depreciation & Amortization Expense 28.31M 34.59M 38.61M 40.06M 37.38M
Depreciation - - 34.4M 37M 35.2M
Amortization of Intangibles - - 4.21M 3.06M 2.18M
Gross Income 760.68M 779.27M 649.4M 606.83M 494.48M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 529.53M 584.56M 536.61M 556.94M 486.66M
Research & Development - - - 0 0
Other SG&A 529.53M 584.56M 536.61M 556.94M 486.66M
Other Operating Expense 0 0 0 0 0
Unusual Expense 400,000 3.4M 583.66M 163.2M 162.79M
EBIT after Unusual Expense (400,000) (3.4M) (583.66M) (163.2M) (162.79M)
Non Operating Income/Expense 760,000 22,000 (840,000) 5.02M 4.33M
Non-Operating Interest Income 213,000 435,000 231,000 65,000 54,000
Equity in Affiliates (Pretax) 2.34M 3.02M 1.49M 1.7M 1.52M
Interest Expense 11.67M 9.2M 8.82M 12.17M 4.41M
Gross Interest Expense 11.67M 9.2M 8.82M 12.17M 4.41M
Interest Capitalized 0 0 0 0 0
Pretax Income 222.39M 185.58M (478.8M) (118.7M) (153.48M)
Income Tax 86.17M 72.31M (103.43M) (21.4M) (58.77M)
Income Tax - Current Domestic 64.57M 46.41M 18.57M 9.8M (1.7M)
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic 21.6M 25.9M (122M) (31.2M) (57.07M)
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 - 0
Equity in Affiliates 0 0 0 - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 136.22M 113.27M (375.38M) (97.3M) (94.7M)
Minority Interest Expense 386,000 693,000 122,000 (15M) (1.6M)
Net Income 135.84M 112.58M (375.5M) (82.31M) (93.11M)
Extraordinaries & Discontinued Operations 0 0 (6.97M) (1.28M) (3.07M)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 (6.97M) (1.28M) (3.07M)
Net Income After Extraordinaries 135.84M 112.58M (382.46M) (83.59M) (96.18M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 135.84M 112.58M (375.5M) (82.31M) (93.11M)
EPS (Basic) 4.99 4.02 (13.33) (2.79) (3.08)
Basic Shares Outstanding 27.23M 28.03M 28.69M 29.9M 31.25M
EPS (Diluted) 4.89 3.95 (13.33) (2.79) (3.08)
Diluted Shares Outstanding 27.76M 28.48M 28.69M 29.9M 31.25M
EBITDA 259.46M 229.3M 151.4M 89.96M 45.2M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)